WOWI, Inc. (OTCPK: WOWU)
Health Care · Pharmaceuticals · US
$—
— today · — 1Y
WOWI, Inc. (OTCPK: WOWU) operates in the Pharmaceuticals industry within the Health Care sector. The company is valued at $33.00 and employs 0 people.
trading between 0.00 and 0.00.
Tweenvest scores WOWI, Inc. across four factors: quality 14/100. Its strongest factor is quality.
WOWU price history
Not enough price history to draw a chart yet.
Key figures
- Market cap
- $33.00
- Revenue (TTM)
- —
- P/E
- —
- EPS
- -1.00
- Dividend yield
- —
- Beta (5Y)
- -35.06
- 52-week high
- $0.00
- 52-week low
- $0.00
- Avg volume (3M)
- —
- Shares outstanding
- 33.21M
- Employees
- 0
- Next earnings
- —
About WOWI, Inc.
WOWI, Inc. is an emerging enterprise that specializes in licensing intellectual property and technological solutions to businesses within the regulated cannabis sector across the United States. Beyond its core licensing operations, the company provides essential packaging and labeling materials, alongside leasing options for both equipment and real estate to various companies. Furthermore, WOWI, Inc. offers an extensive array of advisory services, encompassing optimal business frameworks and operational guidance. These services are tailored for diverse stakeholders in the legal cannabis space, including cultivators, producers, extractors, and retail dispensaries, all operating in compliance with state laws governing medicinal and/or recreational cannabis. The firm's corporate headquarters are situated in Centennial, Colorado.
- ISIN
- US92940M1018
- Listed since
- Feb 2, 1995
- Exchange
- Pink Sheets LLC
- Currency
- USD
Other Pharmaceuticals companies
| Company | Market cap | Price | Day |
|---|---|---|---|
| Eli Lilly and CompanyNYSE: LLY | $1.12T | $1,255.40 | +0.88% |
| Johnson & JohnsonNYSE: JNJ | $651.25B | $270.24 | +1.07% |
| Merck & Co., Inc.NYSE: MRK | $376.37B | $152.55 | +2.39% |
| Roche Holding AGSWX: ROP | $373.91B | CHF375.60 | +1.02% |
| Novartis AGSWX: NOVN | $302.17B | CHF127.42 | +0.85% |
| AstraZeneca PLCLSE: AZN | $258.76B | £122.40 | +1.26% |
| Novo Nordisk A/SCPSE: NOVO B | $207.84B | Dkr300.85 | +1.59% |
| Pfizer Inc.NYSE: PFE | $159.99B | $28.07 | +1.01% |
Figures last refreshed Aug 18, 2026.